Extended Data Fig. 4: Impact of Doxy-PEP use on tetracycline ARGs by number of doxycycline doses received for DNA-seq samples (a, b) and RNA-seq samples (c, d). | Nature Medicine

Extended Data Fig. 4: Impact of Doxy-PEP use on tetracycline ARGs by number of doxycycline doses received for DNA-seq samples (a, b) and RNA-seq samples (c, d).

From: Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome

Extended Data Fig. 4

(a, c) Tetracycline ARG richness and (b, d) proportion of tetracycline ARG mass within the resistome by number of doxycycline doses received was plotted and fitted to a linear regression line for the outcome of tetracycline ARG richness and an inflated beta-regression line for the outcome of proportional tetracycline mass (DNA-seq: n = 127 samples, RNA-seq: n = 86 samples). The regression model is shown as a line, and the gray shaded areas surrounding the regression lines show the 95% confidence intervals. P-values from the regression models are obtained by two-sided Wald tests. Significant p-values (<0.05) are bolded. Significant p-values (<0.05) are bolded. Abbreviations: ARG, antimicrobial resistance gene; p.adj, adjusted p-value.

Back to article page